Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

AUTOR(ES)

Preiss, David

FONTE

American Diabetes Association

Documentos Relacionados

• Heart Failure: An Overview of Morbidity and Mortality in Rio Grande do Sul
• Association of HDL cholesterol and triglycerides with mortality in patients with heart failure
• Comorbid Psychiatric Disorders and Predictors of Pain Management Program Success in Patients With Chronic Pain
• Shared care helps reduce mortality in patients with heart failure
• Inspiratory muscle endurance in patients with chronic heart failure.